Home
Telix Pharmaceuticals TLX paid Liberty Partners Group $40K for lobbying in Q2 2026 · Health Issues, Medicare and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $40,000
- Quarter
- Q2 2026
- Client
- Telix Pharmaceuticals US
- Reported
- 26/07/20
Down 20.0% from last quarter
What else happened in Telix Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 05/31~07/30Telix Pharmaceuticals US's other lobbying reports
- Telix Pharmaceuticals US
LobbyingTelix Pharmaceuticals
LobbyingTelix Pharmaceuticals
TLX
$50K
$50K
Reported 04/17
for Q1
- Telix Pharmaceuticals US
LobbyingTelix Pharmaceuticals
LobbyingTelix Pharmaceuticals
TLX
Under $5,000
Under $5,000
Reported 04/07
for Q1
- Telix Pharmaceuticals US
LobbyingTelix Pharmaceuticals
LobbyingTelix Pharmaceuticals
TLX
$52K
$52K
Reported 01/20
for Q4 2025
- Telix Pharmaceuticals US
LobbyingTelix Pharmaceuticals
LobbyingTelix Pharmaceuticals
TLX
$13K
$13K
Reported 01/08
for Q4 2025
- Telix Pharmaceuticals US
LobbyingTelix Pharmaceuticals
LobbyingTelix Pharmaceuticals
TLX
Under $5,000
Under $5,000
Reported 25/10/20
for Q3 2025